BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8546844)

  • 1. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
    Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
    APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients.
    Dreinhöfer KE; Akerman M; Willén H; Anderson C; Gustafson P; Rydholm A
    Int J Cancer; 1994 Nov; 59(3):379-82. PubMed ID: 7927945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
    Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Baldetorp B; Fernö M; Alvegård T; Rydholm A
    APMIS; 1994 Dec; 102(12):915-24. PubMed ID: 7888160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.
    Hoyt JW; Gown AM; Kim DK; Berger MS
    J Neurooncol; 1995; 24(2):163-9. PubMed ID: 7562003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
    Yang WI; Efird JT; Quintanilla-Martinez L; Choi N; Harris NL
    Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histocytoma.
    Brinck U; Stachura J; Kellner S; Schauer A
    Anticancer Res; 1995; 15(5B):1915-9. PubMed ID: 8572578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
    Cher ML; Chew K; Rosenau W; Carroll PR
    Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
    Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
    Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma.
    Engellau J; Akerman M; Anderson H; Domanski HA; Rambech E; Alvegård TA; Nilbert M
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):358-63. PubMed ID: 11759064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
    Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.